InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NBL | Ann: Final share buy-back notice - Appendix 3F | 06/09/19 | 0 | 1 | |||
|
|||||||
NBL | Ann: Daily share buy-back notice - Appendix 3E | 06/09/19 | 0 | 1 | |||
|
|||||||
NBL | Ann: NBL - ASX Announcement | 26/03/19 | 0 | 67 | |||
|
|||||||
NBL | Ann: ASIC Forms 484 Share Cancellation | 20/03/19 | 0 | 61 | |||
|
|||||||
NBL | Ann: Daily and final share buy-back notice - Appendix 3E & 3F | 13/03/19 | 0 | 112 | |||
|
|||||||
NBL | Ann: Appendix 3B - Employee Shares | 01/03/19 | 0 | 120 | |||
|
|||||||
NBL | Ann: Announcement of buy-back - Appendix 3C | 27/02/19 | 2 | 507 | |||
|
|||||||
NBL | Ann: Final share buy-back notice - Appendix 3F | 22/02/19 | 0 | 100 | |||
|
See All Discussions